Innovating Works
NMP-30-2015
NMP-30-2015: Next generation tools for risk governance of nanomaterials
Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relationships is inadequate for enabling safe use for newly developed materials in the fast moving market of nanomaterials. The challenge is to build a state-of-the art and flexible risk banding tool to keep pace with developments in innovation and risk research by harvesting and implementing results from concluded, ongoing and planned research in next generation risk governance frameworks. For nanotechnology, as with any new and rapidly evolving technology, analysis of risk is technically and methodologically limited, and thus associated with a high degree of uncertainty which should be understood and quantified. Stakeholders' concerns, including those of the insurance sector, and risk perception should be understood and communicated. Risk acceptance is strongly affected by a clear understanding of the risks, the benefits and the uncertainties perceived on equity and trust.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 26-03-2015.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relationships is inadequate for enabling safe use for newly developed materials in the fast moving market of nanomaterials. The challenge is to build a state-of-the art and flexible risk banding tool to keep pace with developments in innovation and risk research by harvesting and implementing results from concluded, ongoing and planned research in next generation risk governance frameworks. For nanotechnology, as with any new and rapidly evolving technology, analysis of risk is technically and methodologically limited, and thus associated with a high degree of uncertainty which should be understood and quantified. Stakeholders' concerns, including those of the insurance sector, and risk perception should be understood and communicated. Risk acceptance is strongly affected by a clear understanding of the risks, the benefits and the uncertainties perceived on equity and trust.

Scope: Research should focus on the testing, the calibration and the further development of risk prioritisation (or banding) tools for both human and environment... ver más

Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relationships is inadequate for enabling safe use for newly developed materials in the fast moving market of nanomaterials. The challenge is to build a state-of-the art and flexible risk banding tool to keep pace with developments in innovation and risk research by harvesting and implementing results from concluded, ongoing and planned research in next generation risk governance frameworks. For nanotechnology, as with any new and rapidly evolving technology, analysis of risk is technically and methodologically limited, and thus associated with a high degree of uncertainty which should be understood and quantified. Stakeholders' concerns, including those of the insurance sector, and risk perception should be understood and communicated. Risk acceptance is strongly affected by a clear understanding of the risks, the benefits and the uncertainties perceived on equity and trust.

Scope: Research should focus on the testing, the calibration and the further development of risk prioritisation (or banding) tools for both human and environmental risks, with emphasis on:

a) the use of inputs from computational toxicology and/ or ‘high concern grouping approaches’ in risk banding tools to identify potential hot spots for risk,

b) Scientific foundation of the ‘risk bands’, by linking the hazard based with ‘dose’ relevant exposure banding,

c) Inclusion of data and monitoring strategies on the efficacy of risk mitigation measures and

d) Alignment with user capacities and needs, including ensuring the ability of the nanomaterial sector to avail of risk transfer/insurance. 

The selected project should identify the major processes of individual and societal decision making, placing particular attention on the aspect of uncertainty. To ensure the highest possible quality in regulatory decision making, emphasis should be given to the development of guidance for important issues in Risk Assessment, based on in-depth analysis of the current scientific basis concerning the addressed hazards and the possible exposure, and joining forces with other projects

Activities expected to focus on Technology Readiness Level 5.

The Commission considers that proposals requesting a contribution from the EU between EUR 6 and 8 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts. No more than one proposal will be funded.

Expected impact:

•  A framework for the risk governance of nanomaterials entering the market by developing tools for risk appraisal, risk transfer and guidance for risk communication;

•  Demonstration in specific industrial settings or industrial sectors of the feasibility of the developed approaches and tools through worked examples as case studies and pilots with outcomes as guidance, good practices and tools for risk management and risk communication;

•  Leveraging and building on current knowledge related to hazard mapping, exposure and control banding and risk prioritization as well on inter/national and company level risk governance and risk dialogue efforts with key stakeholders including regulators and insurers.

Type of action: Research & Innovation Actions


Cross-cutting Priorities:International cooperation


ver menos

Temáticas Obligatorias del proyecto: Temática principal: Environment and health risks occupational medicin Nano-materials (production and properties) Toxicology Nano-technology

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relationships is inadequate for enabling safe use for newly developed materials in the fast moving market of nanomaterials. The challenge is to build a state-of-the art and flexible risk banding tool to keep pace with developments in innovation and risk research by harvesting and implementing results from concluded, ongoing and planned research in next generation risk governance frameworks. For nanotechnology, as with any new and rapidly evolving technology, analysis of risk is technically and methodologically limited, and thus associated with a high degree of uncertainty which should be understood and quantified. Stakeholders' concerns, including those of the insurance sector, and risk perception should be understood and communicated. Risk acceptance is strongly affected by a clear understanding of the risks, the benefits and the uncertainties perceived on equity and trust. Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relationships is inadequate for enabling safe use for newly developed materials in the fast moving market of nanomaterials. The challenge is to build a state-of-the art and flexible risk banding tool to keep pace with developments in innovation and risk research by harvesting and implementing results from concluded, ongoing and planned research in next generation risk governance frameworks. For nanotechnology, as with any new and rapidly evolving technology, analysis of risk is technically and methodologically limited, and thus associated with a high degree of uncertainty which should be understood and quantified. Stakeholders' concerns, including those of the insurance sector, and risk perception should be understood and communicated. Risk acceptance is strongly affected by a clear understanding of the risks, the benefits and the uncertainties perceived on equity and trust.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions:
For single-stage and second-stage evaluations, the threshold for the criteria Excellence and Impact will be 4. The overall threshold, applying to the sum of the three individual scores, will be 12.
In case of equal overall scores in the ranked list, the priority order of proposals will be established in accordance with part H of the General Annexes, except that proposals will be ranked on the basis of individual scores for the Impact criterion before the Excellence criterion.
3.2 Guide to the submission and evaluation process
 
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Indicative timetable for evaluation and grant agreement:
Information on the outcome of two-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of infor...
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions:
For single-stage and second-stage evaluations, the threshold for the criteria Excellence and Impact will be 4. The overall threshold, applying to the sum of the three individual scores, will be 12.
In case of equal overall scores in the ranked list, the priority order of proposals will be established in accordance with part H of the General Annexes, except that proposals will be ranked on the basis of individual scores for the Impact criterion before the Excellence criterion.
3.2 Guide to the submission and evaluation process
 
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Indicative timetable for evaluation and grant agreement:
Information on the outcome of two-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
Annotated Model Grant Agreement
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply.
Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-NMP-2014-2015 Next generation tools for risk governance of nanomaterials Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relatio...
Sin info.
NMP-06-2015 Novel nanomatrices and nanocapsules
en consorcio: Scope:Specific challenge: Encapsulation technologies have been widely used for a long time in the pharmaceutical industry for drug delivery...
Cerrada hace 10 años | Próxima convocatoria prevista para el mes de
NMP-12-2015 Biomaterials for treatment and prevention of Alzheimer's disease
en consorcio: Scope:Specific challenge: An estimated 7.3 million Europeans between 30 and 99 years of age suffered from different types of dementias in th...
Cerrada hace 10 años | Próxima convocatoria prevista para el mes de
NMP-30-2015 Next generation tools for risk governance of nanomaterials
en consorcio: Scope:Specific challenge: The conventional risk assessment approach, i.e. deriving no-effect levels or limit values from dose-effect relatio...
Cerrada hace 10 años | Próxima convocatoria prevista para el mes de
NMP-02-2015 Integration of novel nano materials into existing production lines
en consorcio: Scope:Specific challenge: Nanomaterials are intended to improve the performance of existing production technologies, and to give new functio...
Cerrada hace 10 años | Próxima convocatoria prevista para el mes de
NMP-03-2015 Manufacturing and control of nanoporous materials
en consorcio: Scope:Specific challenge: There is a constantly growing interest in nanostructured porous materials, thanks to the many applications that ca...
Cerrada hace 10 años | Próxima convocatoria prevista para el mes de